Table 2.
Genes in intervention group with the expression up-regulated and down-regulated compared to positive control group
| Genebank encode number | Expression ratio intervention group/positive control group | Gene name (abbreviation) | Gene function |
|---|---|---|---|
| NM_001271166 | 2.75 | Prostaglandin-endoperoxide synthase 1 (PTGS1) | Protease |
| NM_000633 | 2.60 | B-cell CLL/lymphoma 2 (BCL2) | Apoptosis |
| NM_000577 | 2.20 | Interleukin 1 receptor antagonist (IL1RN) | Cytokine |
| NM_001190945 | 1.80 | TNF receptor-associated factor 1 (TRAF1) | Signal transduction |
| NM_001554 | 1.80 | Cysteine-rich angiogenic inducer, 61 (CYR61) | Apoptosis |
| NM_004938 | 1.60 | Death-associated protein kinase 1 (DAPK1) | Apoptosis |
| NM_001947 | 1.40 | Dual specificity phosphatase 7 (DUSP7) | Apoptosis |
| NM_001718 | 0.58 | Bone morphogenetic protein 6 (BMP6) | Cytokine |
| NM_002427 | 0.53 | Matrix metallopeptidase 13 (MMP13) | Protease |
| NM_000963 | 0.51 | Prostaglandin-endoperoxide synthase2 (PTGS2) | Protease |
| NM_001552 | 0.51 | Insulin-like growth factor binding protein 4 (IGFBP4) | Signal transduction |
| NM_004878 | 0.46 | Prostaglandin E synthase (PTGES) | Protease |
| NM_001171623 | 0.46 | Vascular endothelial growth factor A (VEGFA) | Cytokine |
| NM_000958 | 0.29 | Prostaglandin E receptor 4 (PTGER4) | Signal transduction |
| NM_001190942 | 0.27 | Tumor necrosis factor (ligand) superfamily, member 10 (TNFSF10) | Apoptosis |